Stockscreener 앱 받기
15.53
2.70%
0.3648
전일 마감가:
$15.17
열려 있는:
$15.5
하루 거래량:
727.95K
Relative Volume:
0.38
시가총액:
$2.38B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-11.59
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
+7.67%
1개월 성능:
+23.55%
6개월 성능:
+96.22%
1년 성능:
+215.38%
1일 변동 폭
$15.21
$15.94
1주일 범위
$14.11
$15.94
52주 변동 폭
$4.27
$15.94
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
15.60 | 2.31B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.30 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.66 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.06 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.20 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.64 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | Guggenheim | Buy |
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.57 - Markets Mojo
Is Adaptive Biotechnologies Corporation stock near bottom after declineEarnings Recap Report & Free High Return Stock Watch Alerts - newser.com
Adaptive Biotechnologies Hits Day High with 8.36% Surge in Stock Price - Markets Mojo
Risk vs reward if holding onto Adaptive Biotechnologies CorporationLong Setup & Risk Controlled Daily Trade Plans - newser.com
Will Adaptive Biotechnologies Corporation bounce back from current support2025 Short Interest & Target Return Focused Stock Picks - newser.com
Adaptive Biotechnologies stock hits 52-week high at $15.29 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $15.29 - Investing.com
Adaptive Biotechnologies (ADPT): A Fresh Analyst Spotlight Prompts a Closer Look at Valuation and Growth Potential - simplywall.st
What technical signals suggest for Adaptive Biotechnologies Corporation stockJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
Can volume confirm reversal in Adaptive Biotechnologies CorporationJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Why analysts upgrade Adaptive Biotechnologies Corporation stock2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock bottoming after sell offJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Adaptive Biotechnologies Corporation trending in predictive chart modelsQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
What recovery options are there for Adaptive Biotechnologies CorporationJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
Why Adaptive Biotechnologies (ADPT) Is Up 8.5% After clonoSEQ’s Integration With Flatiron Health’s OncoEMR - simplywall.st
Is Adaptive Biotechnologies Corporation stock poised for growthJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Adaptive Biotechnologies Corporation stock momentum explainedJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Adaptive Biotechnologies Corp. Hits New 52-Week High of $15.26 - Markets Mojo
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Adaptive Biotechnologies Corp. Hits New 52-Week High at $15.04 - Markets Mojo
Adaptive Biotechnologies Hits Day High with 13.94% Surge in Stock Price - Markets Mojo
Adaptive Biotechnologies stock hits 52-week high at $14.49 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ:ADPT) Now Covered by Analysts at Guggenheim - Defense World
A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts - Benzinga
Guggenheim Initiates Coverage on ADPT with 'Buy' Rating | ADPT S - GuruFocus
Adaptive Biotechnologies stock hits 52-week high at $14.49 - Investing.com
Guggenheim Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $20 - 富途牛牛
Will Adaptive Biotechnologies Corporation (1HM) stock gain from lower interest ratesWeekly Investment Summary & Free Real-Time Volume Trigger Notifications - newser.com
Real time alert setup for Adaptive Biotechnologies Corporation performanceWeekly Risk Summary & Step-by-Step Trade Execution Guides - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock dividend growth reliableCEO Change & Entry Point Strategy Guides - newser.com
Adaptive Biotechnologies Corporation stock outlook for YEARSwing Trade & Safe Swing Trade Setups - newser.com
The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook - Yahoo Finance
Adaptive Biotechnologies (ADPT): Exploring Valuation After Recent Share Price Momentum - Yahoo Finance
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance
Adaptive Biotechnologies Stock Hits Day Low of $12.72 Amid Price Pressure - Markets Mojo
Adaptive Biotechnologies Corp. Hits New 52-Week High at $14.27 - Markets Mojo
Adaptive Biotechnologies Corp. Hits New 52-Week High of $14.47 - Markets Mojo
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adaptive Biotechnologies Corp 주식 (ADPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Option Exercise |
6.32 |
68,412 |
432,364 |
1,347,936 |
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Sale |
7.35 |
68,412 |
502,828 |
1,279,524 |
1.18%
자본화:
|
볼륨(24시간):